Browse studies

Find your next paid study

1 recruiting study matching your filters

Pilot Single Arm Phase 2 Study of Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

This is a prospective, single-arm phase 2 pilot study to assess the response rate of IDH1 mutated relapsed/refractory acute myeloid leukemia (AML) patients who…

IDH1 MutationRelapsed / Refractory AML

Timothy PardeeNCT07471841